![Adrian Quartel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adrian Quartel
Hoofd Techniek/Wetenschap/O&O bij
SPRUCE BIOSCIENCES, INC.
Vermogen: 139 428 $ op 30-06-2026
Profiel
Adrian Quartel is Chief Medical Officer at Spruce Biosciences, Inc. since 2026.
Former roles include Chief Medical Officer at Zevra Therapeutics, Inc. from 2024 to 2026, Chief Medical Officer at Acer Therapeutics, Inc. from 2022 to 2023, Chief Medical Officer at Adamas Pharmaceuticals LLC from 2020 to 2022, and Head-Medical Affairs at BioMarin Pharmaceutical, Inc. from 2017 to 2020.
Education includes a doctorate from Erasmus University Rotterdam and a graduate degree from The Royal College of Physicians.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-01-2026 | 9.723 ( 0,02% ) | 139 428 $ | 30-06-2026 |
Actieve functies van Adrian Quartel
| Bedrijven | Functie | Begin |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 27-07-2026 |
Eerdere bekende functies van Adrian Quartel
| Bedrijven | Functie | Einde |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 03-07-2026 |
| ACER THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
| ADAMAS PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-02-2022 |
| BIOMARIN PHARMACEUTICAL INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2020 |
Opleiding van Adrian Quartel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
57
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
Spruce Biosciences, Inc.
 Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders | Health Technology |
